| Date | Time | Source | |
| 05/23/2013 | 6:00AM | PRNUS | PAREXEL International To Present At Jefferies Healthcare Conference
PAREXEL International To Present At Jefferies Healthcare Conference PR Newswire BOSTON, May 23, 2013 BOSTON, May 23, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Healthcare Conference in New York. James Winschel, Sr. Vice President... More...>> |
| 05/02/2013 | 8:44AM | ZACKS | Charles River Misses Estimates in 1Q - Analyst Blog
Charles River Laboratories (CRL) reported first quarter 2013 earnings (excluding special items) of 63 cents per share, missing the Zacks Consensus Estimate of 71 cents. Earnings were roughly flat year over year. Charles River’s net sales of $291.2 million increased 1.8% year over year in the first quarter of... More...>> |
| 04/30/2013 | 4:20PM | PRNUS | PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results - Service revenue of $454.5 million, up 27.7% year-over-year - GAAP operating margin of 8.1% improves sequentially from 7.4% in the second quarter - CRS gross margin improves sequentially to 27.9% from 24.4% in the second quarter - GAAP diluted earnings... More...>> |
| 04/30/2013 | 4:02PM | PRNUS | PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy PR Newswire BOSTON, April 30, 2013 BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the... More...>> |
| 04/24/2013 | 6:00AM | PRNUS | PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award
PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award Award highlights success of innovative strategic partnership at 22nd Annual Partnerships in Clinical Trials conference in Orlando, FL PR Newswire BOSTON, April 24, 2013 BOSTON, April 24, 2013 /PRNewswire/ -- PAREXEL International Corporation... More...>> |
| 04/22/2013 | 8:00AM | PRNUS | New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry PR Newswire BOSTON, April 22, 2013 - Majority of biopharma executives believe Strategic Partnerships positively impact their engagement with CROs BOSTON, April 22, 2013 /PRNewswire/ -- PAREXEL International... More...>> |
| 04/22/2013 | 8:00AM | PRNUS | New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry Majority of biopharma executives believe Strategic Partnerships positively impact their engagement with CROs PR Newswire BOSTON, April 22, 2013 BOSTON, April 22, 2013 /PRNewswire/ -- PAREXEL International... More...>> |
| 04/05/2013 | 2:38PM | ZACKS | New Version of IMPACT CTMS in Market - Analyst Blog
Recently, a subsidiary of PAREXEL International Corp (PRXL), Perceptive Informatics, introduced an upgraded version of its IMPACT clinical trial management system (CTMS). IMPACT CTMS solution reports, plans and tracks clinical trials, for its clients which includes many pharmaceutical and biotechnology companies. According... More...>> |
| 04/03/2013 | 6:00AM | PRNUS | Perceptive Informatics Improves Clinical Trial Management With New Release Of IMPACT® CTMS Solution
Perceptive Informatics Improves Clinical Trial Management With New Release Of IMPACT® CTMS Solution eClinical leader advances clinical trial management system for utmost flexibility and configurability PR Newswire BOSTON, April 3, 2013 BOSTON, April 3, 2013 /PRNewswire/ -- Perceptive Informatics, a leading eClinical solutions... More...>> |
| 04/02/2013 | 9:45AM | PRNUS | PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call PR Newswire BOSTON, April 2, 2013 BOSTON, April 2, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2013 on Tuesday, April 30, 2013 after... More...>> |
| 03/19/2013 | 8:00AM | PRNUS | Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL...
Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals PR Newswire NEW YORK, March 19, 2013 NEW YORK, March 19, 2013 /PRNewswire/ -- Today, Wall Street... More...>> |
| 03/14/2013 | 4:02PM | PRNUS | PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase A...
PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan PR Newswire BOSTON, March 14, 2013 BOSTON, March 14, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) today provided an update... More...>> |
| 02/28/2013 | 6:00AM | PRNUS | PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference
PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference PR Newswire BOSTON, Feb. 28, 2013 BOSTON, Feb. 28, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference... More...>> |
| 02/20/2013 | 6:00AM | PRNUS | PAREXEL International To Present At Citi Global Healthcare Conference
PAREXEL International To Present At Citi Global Healthcare Conference PR Newswire BOSTON, Feb. 20, 2013 BOSTON, Feb. 20, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Citi Global Healthcare Conference in New York. James Winschel, Sr. Vice President... More...>> |
| 02/19/2013 | 9:58AM | ZACKS | ESRX Reports In-Line 4Q Earnings - Analyst Blog
Express Scripts Holding Company’s (ESRX) fourth quarter 2012 adjusted earnings of $1.05 per share were in-line with the Zacks Consensus Estimate, and increased 28.1% from the year-ago period. Higher revenues aided earnings in the fourth quarter of 2012. On a reported basis (including special items), earnings grew... More...>> |
| 02/14/2013 | 10:27AM | ZACKS | Mixed 4Q for Charles River - Analyst Blog
Charles River Laboratories (CRL) reported fourth quarter 2012 earnings (excluding special items) of 64 cents per share, beating the Zacks Consensus Estimate of 60 cents. Earnings declined 7.2% from the year-ago earnings of 69 cents due to lower revenues. Charles River’s net sales of $280.1 million decreased 3.7... More...>> |
| 01/30/2013 | 9:17AM | DJN | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Amazon.com Inc. (AMZN), Copano Energy LLC (CPNO) and Chesapeake Energy Corp. (CHK). Amazon.com posted a 45% drop in earnings in the fourth quarter, but some other measures of the online retailer's profitability came as a positive surprise... More...>> |
| 01/30/2013 | 6:37AM | DJN | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Amazon.com Inc. (AMZN), Chesapeake Energy Corp. (CHK) and Isis Pharmaceuticals Inc. (ISIS). Amazon.com posted a 45% drop in earnings in the fourth quarter, but some other measures of the online retailer's profitability came as a positive... More...>> |
| 01/29/2013 | 4:02PM | PRNUS | PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black;... More...>> |
| 01/28/2013 | 3:40AM | ZACKS | All-Front Easy Beat for Covance - Analyst Blog
Covance Inc. (CVD) reported earnings per share (EPS) of 61 cents in the fourth quarter of 2012, higher than the year-ago quarter EPS of 35 cents. The year-over-year increase in earnings was primarily due to a healthy top-line growth and a reduction in share count by 9.6%. Excluding the impact of the one-time items (losses... More...>> |
